A multicenter open-label treatment protocol (HGT-GCB-058) of velaglucerase alfa enzyme replacement therapy in patients with Gaucher disease type 1: safety and tolerability

Gregory M. Pastores,Barry E. Rosenbloom,Neal J. Weinreb,Ozlem Goker-Alpan,Gregory A. Grabowski,Gabriel M. Cohn,David Zahrieh

A multicenter open-label treatment protocol (HGT-GCB-058) of velaglucerase alfa enzyme replacement therapy in patients with Gaucher disease type 1: safety and tolerability

2014

Gregory M. Pastores
Barry E. Rosenbloom
Neal J. Weinreb
Ozlem Goker-Alpan
Gregory A. Grabowski
Gabriel M. Cohn
David Zahrieh

A multicenter open-label treatment protocol (HGT-GCB-058) of velaglucerase alfa enzyme replacement therapy in patients with Gaucher disease type 1: safety and tolerability

Keywords:

Velaglucerase alfa
Pathology
Glucosylceramidase
Medicine
Gastroenterology
OPEN LABEL TREATMENT
Disease
Enzyme replacement therapy
Type 1 Gaucher Disease
Imiglucerase
Surgery
Internal medicine
Tolerability
treatment protocol
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations